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Abstract
The Tmem26 gene encodes a novel protein that we have previously shown to be regulated by hedgehog signalling in the
mouse limb. We now report that Tmem26 expression is spatially and temporally restricted in other regions of the mouse
embryo, most notably the facial primordia. In particular, Tmem26 expression in the mesenchyme of the maxillary and nasal
prominences is coincident with fusion of the primary palate. In the secondary palate, Tmem26 is expressed in the palatal
shelves during their growth and fusion but is downregulated once fusion is complete. Expression was also detected at the
midline of the expanding mandible and at the tips of the eyelids as they migrate across the cornea. Given the spatio-
temporally restricted expression of Tmem26, we sought to uncover a functional role in embryonic development through
targeted gene inactivation in the mouse. However, ubiquitous inactivation of Tmem26 led to no overt phenotype in the
resulting embryos or adult mice, suggesting that TMEM26 function is dispensable for embryonic survival.
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Introduction
Transmembrane protein 26 (Tmem26) encodes a 41.6 kD trans-
membrane protein that is conserved throughout much of animal
evolution but whose function remains unknown. We initially
demonstrated that Tmem26 expression is regulated by the GLI3
transcription factor in the murine anterior limb at 11.5 dpc [1].
GLI3 is primarily responsible for repressing hedgehog signalling,
and the pivotal role of sonic hedgehog in determining digit
number and identity is mediated through regulation of the
cleavage of the full-length GLI3 isoform to a truncated
transcriptional repressor [2,3,4]. Tmem26 expression is convinc-
ingly downregulated in response to loss of GLI3 repressor activity
on the anterior limb bud [1], suggesting that it may also form part
of the complex molecular circuitry governing limb patterning.
However, very little is known about Tmem26 expression in other
tissues or at different embryonic stages.
Here we demonstrate that expression of Tmem26 is temporally
and spatially restricted at a range of mid-gestational embryonic
stages in mice. Most notably, we found highly restricted expression
in the developing facial prominences and palatal structures in a
manner suggesting involvement in formation of both the primary
and secondary palates. Despite this, ubiquitous inactivation of
Tmem26 in the mouse led to no overt developmental or adult
anomalies, suggesting that TMEM26 is not required for
embryonic development.
Results and Discussion
Tmem26 structure and evolution
Tmem26 localises to chromosome 10 in both mice and humans.
In mice, the transcript most commonly represented in expressed
sequence tags (EST) databases is approximately 6 kb and formed
from six exons (Fig. 1A). In addition to this primary transcript,
there is likely to be an additional splice variant that incorporates
an 82 bp exon (exon 2a) after exon 2 in mice (Fig. 1A). Insertion of
exon 2a causes a frameshift and introduces an early stop codon in
exon 3. However, this variant is represented by only a few
sequences in mouse EST databases. Reverse transcriptase-
polymerase chain reaction (RT-PCR) of 13.5 dpc whole mouse
embryo RNA failed to detect the splice variant, although analysis
of various adult tissues detected both the primary and the variant
mRNAs in whole brain, eye, skeletal muscle and heart (Fig. 1B). In
humans, four splice variants are represented in Ensembl databases
(www.ensembl.org - ENSG00000196932). The primary human
transcript, which corresponds to the primary mouse transcript, is
highly represented in EST and mRNA databases, suggesting that
it is the major transcript expressed. All other human splice variants
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codons. No known human splice variants reflect the exon 2a
mouse splice variant.
Tmem26 encodes a predicted protein consisting of 367 and 368
residues in mice and humans respectively, with an estimated mass
of 41.6 kilodaltons (kDa). Online bioinformatic databases do not
predict any recognisable protein structural domains within
TMEM26, although several hydrophobic regions thought to act
as transmembrane domains are predicted. The Tmem26 gene is
also found in Drosophila, and in most animal species studied
appears to be represented by a single orthologue; exceptions
include zebrafish (Danio rerio) and sea squirts (Ciona intestinalis and
Ciona savignyi) which have multiple paralogues.
Structural predictions using online transmembrane prediction
programs (SVMtm [5], TmPred, TMHMM [6], HMMTOP [7]
and Swissprot) suggest that TMEM26 contains between 5 and 8
transmembrane domains, with the most commonly predicted
number being 7. The variation between predictions often depends
on the presence or absence of a leader sequence (which replaces
one transmembrane domain) and the number of domains within
the C-terminal region. The topographic prediction generated by
SVMtm, which recognises leader sequences of known proteins
more accurately than alternative membrane topography predic-
tion programs [5], is shown in Fig. 1C.
Embryonic expression
The expression profile of Tmem26 mRNA in the murine embryo
was investigated at a range of mid-gestational stages using whole
mount in situ hybridisation (WISH). At embryonic stages 8.5, 9.5
and 10.5 dpc, Tmem26 mRNA was not detected by WISH at levels
above background (data not shown). At 11.0 dpc, Tmem26
expression was detected in the mesenchyme of the anterior and
posterior proximal limb bud, at the autopod/zeugopod boundary
(Fig. 2A,F). By 11.5 dpc, forelimb and hindlimb displayed
increased expression within these domains (Fig. 2B,G). We have
shown previously that the anterior domain is lost in Gli3
Xt/Xt mice
that are considered null for Gli3 (see probe BF147423 in [1]). At
12.5 dpc, Tmem26 expression was detected throughout much of
the interdigital space mesenchyme but by 13.5 dpc, this was
limited to the mesenchyme at the margins of the digits (Fig. 2H–J).
By 11.5 dpc, we also detected expression of Tmem26 in a broad
domain across the surface of the flank, and in craniofacial
structures as discussed in more detail below. Other sites of
expression revealed by either WISH or section in situ hybridisa-
tion include the anterior mesenchyme of the stomach at 11.5 dpc
(Fig. 3I), the preputial swellings and proximo-lateral glans of the
genital tubercle from 11.5 dpc to 15.5 dpc (Fig. 2R,S and data not
shown), and a defined region of the hindbrain from 12.5 dpc
(Fig. 3H). This brain region likely corresponds to the nucleus of the
seventh cranial nerve (the facial nerve) in the pons.
Embryonic craniofacial expression
The mammalian face is mostly derived from the frontonasal
bulge and pharyngeal arches. A critical process in development of
the face is the morphogenesis of these progenitor structures into
the lateral nasal, medial nasal, maxillary and mandibular
prominences, and the subsequent expansion and fusion of the
prominences to form the primary and secondary palates and the
lower jaw. Understanding these processes has considerable
importance for human health, as failure of the facial prominences
to fuse is often the underlying cause of midfacial clefting defects
including cleft lip with or without cleft palate - the most common
form of human craniofacial birth defect [8,9,10].
At 11.0 dpc Tmem26 expression was first evident diffusely
throughout the medial and lateral nasal prominences (Fig. 2K). At
11.5 dpc, the posterior region of the medial nasal prominence begins
to fuse with the lateral nasal prominence and the maxillary
prominence to form the upper lip and primary palate. Tmem26 was
found to be expressed in each of these three prominences at this time
point in the underlying mesenchyme adjacent to the regions of fusion
(Fig. 2L). It was also expressed along the posterior margin of the
maxillary prominence and along the medial surface of each medial
nasal prominence near the region where they will ultimately merge at
the midline (Fig. 2L). At 12.5 dpc, Tmem26 became strikingly
restricted within the primary palate (Fig. 2M). At 13.5 dpc, when
primary palate formation is complete, Tmem26 expression was
restricted to the distal tips of the maxillae and the maxillary margins
of the nostrils (Fig. 2N). A zone of expression was also present along
the oral edge of the mandibular prominence, from 11.5 dpc to
13.5 dpc (Fig. 2K–M). This dynamic expression in the facial
Figure 1. Predicted gene and protein structure. (A) Predicted exon structure of Tmem26.( B) RT-PCR across exon2, showing the main Tmem26
transcript incorporating exon2 only, and a minor variant generated by alternative splicing in some tissues (arrow), which incorporates an extra exon
(2a). (C) The topographic prediction for TMEM26 generated by the program SVTtm. Other predictions vary dependent on the presence or absence of
a leader sequence and the number of transmembrane domains. 1,2,3 – non-membrane loops; C-terminus, N-terminus.
doi:10.1371/journal.pone.0025228.g001
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situ hybridisation of transverse sections through the embryonic head
(Fig. 3E–G9). In particular, no expression was detected prior to
11.0 dpc. Onset of Tmem26 expression at this late stage suggests that
Tmem26 may not be involved in jaw patterning but could play a role
in lip or secondary palate fusion.
The striking expression of Tmem26 in the primary palate
prompted us to investigate the secondary palate, the formation of
which is distinct from that of the primary palate but shares many
common genetic pathways and cellular mechanisms. The palatal
shelves emerge from the oral surface of the maxillae at 12.5 dpc.
The shelves expand, reorient and ultimately fuse around 14.5 dpc
to divide the oral from the nasal cavity. By WISH we detected
Tmem26 expression in the palatal shelves prior to fusion (Fig. 2O).
However, as regions of the palate begin to fuse at 14.5 dpc, Tmem26
appeared to be downregulated in the neighbouring mesenchyme
(Fig. 2P). By 15.5 dpc, when fusion is essentially complete,
expression in the secondary palate is greatly reduced (Fig. 2Q).
This expression was also confirmed by radioisotopic section in situ
hybridisation (Fig. 3A–D9). The mesenchyme of the vertical palatal
shelves expressed Tmem26 from the time of emergence at 12.5 dpc,
through 13.5 dpc (Fig. 3A,B). By 14.5 dpc when the palatal shelves
have reoriented in most embryos, expression was still evident
throughout the mesenchyme (Fig. 3C), but this was rapidly
downregulated following fusion and degeneration of the medial
epithelial seam at 15.5 dpc (Fig. 3D).
Other sites of Tmem26 expression within the craniofacial complex
included the nasal conchae (not shown) and septum, extra-ocular
mesenchyme, extrinsic muscles of the eye, and the base of the
tongue (Fig. 3A–D9). At 15.5 dpc, Tmem26 expression was also
detected in the ectodermally-derived periderm and epithelia at the
tip of the developing eyelid (Fig. 3J). At this time point, the eyelids
are migrating across the cornea to fuse at the equator. Expression
was not detected in the developing teeth or Meckel’s cartilage.
Adult expression
Publiclyavailablearraydata(http://symatlas.gnf.org/SymAtlas/
symform) demonstrates low level expression of Tmem26 in a wide
Figure 2. Expression of Tmem26 in wild-type embryos by whole mount in situ hybridisation analysis. (A–E) Whole embryos aged
11.0 dpc-14.5 dpc. No expression was detected before 11.0 dpc. (F–J) Forelimbs of corresponding embryos shown in A–E, dorsal view, limb anterior
is to the top. (K,L) At 11.0 and 11.5 dpc Tmem26 expression in the facial prominences is restricted primarily to mesenchyme underlying areas of facial
prominence fusion and merging. (M) At 12.5 dpc striking expression is observed in the primary palate, and expression remains at the midline of the
mandible. (N) After fusion is complete at 13.5 dpc, expression is restricted to maxillary tissue at the distal tip of the snout. (O,P) The developing
secondary palate at 14.5 dpc, taken from below with the mandible removed, one showing the palatal shelves wide apart, and one as the shelves are
coming together to fuse. Tmem26 is expressed in the palatal shelves prior to fusion but downregulated upon palate fusion, most obvious at 15.5 dpc
(Q). (R) Ventral and (S) lateral views of a 13.5 dpc genital tubercle. Dorsal-ventral and anterior-posterior axes are indicated. 1p-primary palate, 2p-
secondary palatal shelves, e-external ear, em-extraoccular musculature, fl-forelimb, lnp-lateral nasal prominence, mes-medial epithelial seam, md-
mandible, mnp-medial nasal prominence, mx-maxillary prominence, n-nasal opening, vcm-ventral cephalic mesenchyme.
doi:10.1371/journal.pone.0025228.g002
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was confirmed by real-time quantitative RT-PCR (qRT-PCR) in a
range of adult mouse tissues, although expression was not detected
inprostateortestis,andenhancedlevelsweredetected inmesenteric
lymph nodes, spleen and thymus (Fig. 4). This profile of expression
suggests a possible role for TMEM26 in immune function.
Generation of floxed Tmem26 mice
To investigate the functional role of TMEM26 in various tissues
during embryonic development we generated mice that would
allow conditional inactivation of Tmem26 in a temporal and spatial
manner. LoxP recombination sequences were inserted on either
side of a genomic region of ,1.5 kb containing exon 2 and the
splice variant exon 2a (Fig. 5A). Deletion of exon 2 would remove
a single predicted transmembrane domain and introduce a
frameshift to the transcript, resulting in a premature stop codon
in exon 3 (Fig. 5B). The targeting vector contained 59 and 39
recombination arms each of approximately 5 kb, as well as a
neomycin selection cassette flanked by Frt sites for removal of this
cassette if required.
The Tmem26 targeting construct was electroporated into C2
embryonic stem cells (ES) derived from the C57BL/6 mouse
strain. The C57BL/6 background was selected because of its
susceptibility to craniofacial defects in a number of alternative
mouse models, such as Gli3 and Treacle mutants [11,12]. Resistant
colonies were screened for targeted recombination using PCR and
Southern blot analysis. The 768 bp hybridisation probe binds the
genomic DNA 39 of the targeting vector homologous region
(Fig. 5A). Hybridisation of this probe to EcoRV digested DNA
identifies the wild type allele (Tmem26
+), the targeted allele
(Tmem26
c), and also the deleted allele produced by CRE-mediated
recombination (Tmem26
Ex22; Fig. 5C). Correctly targeted ES cells
were injected into C57BL/6 blastocysts, and chimeric offspring
Figure 3. Expression of Tmem26 in wild-type embryos by section in situ hybridisation. (A–D, E–G,J) radioisotopic; (H,I) DIG detection. (A–
D) Transverse sections through the secondary palate at indicated stages. At 12.5 dpc and 13.5 dpc Tmem26 is expressed in mesenchyme of the
vertical palatal shelves. At 14.5 dpc the shelves have fused but the medial epithelial seam still remains and expression within the mesenchyme is
apparent. By 15.5 dpc the epithelial seam is absent and Tmem26 expression is virtually undetectable. (A9–D9) Corresponding serial sections stained
with toluidine blue. (E–G) Sections through the facial prominences and primary palate region at indicated stages. Tmem26 is not detected at 10.5 dpc
but is upregulated at 11.5 dpc and 12.5 dpc. (E9–G9) Corresponding sections stained with toluidine blue. (H) Parasagittal section through the lateral
hindbrain at 12.5 dpc, showing expression in the nucleus of the seventh facial nerve region within the pons. (I) Longitudinal section through the
stomach at 11.5 dpc, showing expression in the anterior stomach mesenchyme. (J) Magnification of the left eyelid from D,( J9) same section
counterstained with haematoxylin. 1p-primary palate, bt-mesencyme at the base of the tongue, c-cornea, el-eyelid, em-extraocular mesenchyme and
developing extrinsic muscles of the eye, ep-epithelim, L-eye lens, lnp-lateral nasal prominence, n7-nucleus of the seventh facial nerve, mn-mandible,
mnp-medial nasal prominence, mx-maxillary prominence, ns-nasal septum, p-palatal shelf, pd-eyelid periderm, st-stomach mesenchyme. Size bars
indicate 1 mm.
doi:10.1371/journal.pone.0025228.g003
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transmission in a number of lines.
Ubiquitous inactivation of Tmem26
Tmem26
c/c mice were crossed to CMV-Cre mice [13] expressing
Cre recombinase ubiquitously, resulting in inactivation of Tmem26
in all cells including germ cells. Mice homozygous for the deleted
allele in subsequent generations were therefore Tmem26 mutants
(Tmem26
Ex22/Ex22). Surprisingly, these animals were viable and
fertile as adults and showed no detectable evidence of abnormal
embryonic development. Unavailability of an antibody that
reliably detects TMEM26 precluded confirmation of loss of
protein in these mice. However, Southern analysis confirmed that
the structure of the Tmem26
Ex22 allele was as expected (Fig. 5C).
Furthermore, sequencing of PCR products generated for geno-
typing of null and floxed mice revealed that the sequence
surrounding both 39 and 59 LoxP sites was as predicted. To
examine the transcriptional products of the Tmem26
Ex22 allele, we
used RT-PCR to amplify across the introduced mutation from
mRNA derived from adult liver and brain. Two forward primers
were designed within exon 1 and reverse primers were designed
within exon 3, 4 and 5, thus allowing 6 separate PCR reactions
that amplify regions that include exon 2. All PCR products were
band purified and sequenced. Two Tmem26 transcripts were
amplified specifically from Tmem26
Ex22/Ex22 tissues. Sequencing
revealed that the larger of these bands represented the expected
mutant transcript lacking exon 2. The smaller band lacked both
exons 2 and 3, indicating that deletion of exon 2 induced a splice
variant that contains exons 1, 4, 5 and 6 (Fig. 5B). Sequencing
demonstrated that both of these Tmem26
Ex22/Ex22 mRNA
isoforms encode proteins in which the region encoded by exon 1
is in-frame, but is followed by nonsense sequence and a premature
stop codon, again confirming correct targeting of the Tmem26
locus.
Consistent with the viability of these mice as adults, genotypes of
animals born from Tmem26
+/Ex22heterozygous matings segregated in
approximately Mendelian ratios (Tmem26
+/+ 26 mice; Tmem26
+/Ex22
65 mice; Tmem26
Ex22/Ex22 39 mice), indicating that the knockout
allele does not cause embryonic or perinatal lethality. These data
suggest that Tmem26 is not essential for embryonic survival. The lack
of embryonic phenotype is unlikely to be due to functional
compensation by a related gene since our bioinformatic analysis
revealed no evidence of paralogous genes in the mouse genome. It is
possible that truncated proteins could be produced from the mutant
transcript and may retain partial or complete Tmem26 function. This
is a consideration common to most conditional knockout models.
However, if proteins were produced from Tmem26
Ex22/Ex22
transcripts, we consider it unlikely that they would retain significant
function, as all possible products would be severely truncated,
inhibited in their insertion and orientation within the membrane or
lacking large regions of highly conserved sequence.
Comparison of mean weight of Tmem26
Ex22/Ex2 and WT
littermates above 3 months of age revealed no significant differences
(data not shown). The expression pattern of Tmem26 predicts
possible defects in the limbs and craniofacial complex. However,
skeletal preparations of adult Tmem26
Ex22/Ex22 and WT mice
revealed no discernible differences in the underlying limb and
craniofacial skeletal elements (Fig. 6C–J). In the limb, all skeletal
elements were present without evidence of gross morphological
alteration. Craniofacially, skeletal preparations and dissection of
more than 30 mutant adults revealed no gross changes in the
mandible or maxillary bones. There was also no evidence of cleft
palate or submucosal cleft palate. In support of this, mutant pup
survival was comparable to wild-type and there was no evidence of
air in the stomachs of mutant mice – a symptom often associated
with suckling difficulties caused by palate or nasal developmental
problems. Tmem26 expression near the base of the developing
tongue and in the eyelid led us to examine mice for ankyloglossia,
eyes-open-at-birth phenotypes and lens dismorphology but, again,
no differences were observed between Tmem26
Ex22/Ex22 and WT
mice. Histological examination of the secondary palate, nasal
septum, tongue and eye in 16.5 dpc mice also revealed no
differences between Tmem26
Ex22/Ex22 and WT mice (Fig. 6K,L).
Although bone structure was not obviously altered in Tme-
m26
Ex22/Ex22 mice, it was possible that subtle differences in bone
shape or size were present but not immediately evident. Other
published mouse models with either low or high penetrance of cleft
palate often present with alternative craniofacial defects. For
example, Egfr mutants have a narrow snout and a shortened
mandible, whereas Irf6, Dlg, Msx1 and Fgf18 mutants have isolated
cleft palate and a shortened snout [14,15,16,17,18,19]. Therefore,
snout length and width was measured for mutant and WT adults,
to identify any subtle disparities (Fig. 6M–O). Comparison of sex-
matched littermates revealed no significant difference in snout
width or length between mutant and WT mice (n=18 females or
20 males of each genotype). However, it remains possible that
subtle differences in shape or mineralisation of craniofacial bones
may be present in Tmem26
Ex22/Ex22 mice, as has been observed in
other models of craniofacial dysmorphology such as Tbx22 mutant
mice [20].
Concluding comments
Here we describe a novel gene with a complex, regulated
pattern of expression that is both spatially and temporally dynamic
during mouse development. We also demonstrate that conditional
deletion of Tmem26 in the mouse resulted in no overt embryonic or
adult phenotype. While the absence of overt phenotypes suggests
that TMEM26 function is not required for embryonic develop-
ment, it remains possible that more subtle phenotypes may
manifest in these mice. Craniofacial development in particular is a
complex process, and multiple mechanisms act to buffer the
Figure 4. Expression of Tmem26 as determined by qRT-PCR.
Graph shows the mean 2
2DCT and the standard error of the mean (SEM).
doi:10.1371/journal.pone.0025228.g004
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It is possible that crossing the Tmem26
Ex22/Ex22 mouse to
alternative background strains or genetic mouse models suscepti-
ble to facial clefting, or exposure to environmental stresses known
to induce such clefts, may reveal a subtle role for TMEM26 in
mediating aspects of facial development. In addition, high
expression of Tmem26 in organs associated with immune function
suggest a possible role in processes related to the immune response.
This possibility is supported by several transcriptional profiling
studies [21,22,23,24], but has yet to be investigated functionally.
Materials and Methods
Ethics statement
All work involving animals was approved by a University of
Queensland Animal Ethics Committee and adhered to strict
ethical guidelines (AEC Approval Number IMB/580/08/PHD).
Whole mount and section in situ hybridisation
Mouse embryos for in situ hybridisation analysis were collected
from wild type C57Bl/6 mice. Embryos were fixed with 4%
paraformaldehyde in phosphate buffered saline for 4 to 24 hours at
4uC. Embryos to be sectioned were embedded in wax and cut at
8 mm thickness. Whole mount and section in situ hybridisation were
performed essentially as previously described [25,26]. RNA probes
were generated by in vitro transcription using nucleotides conjugated
with either digoxygenin (DIG - Roche Diagnostics, Germany) or
35S
(Amersham). Three mouse Tmem26 probes were used for WISH with
similar results; whole mount and section in situ hybridisation data
presented here are entirely derived from genbank clone BF147423,
which localises to the 39UTR. The other probes were the ORF
(1101 bp Refseq NM_177794), and a 39UTRprobe oflength927 bp
from base 1081 relative to the start ATG of NM_177794 (Allen Brain
Atlas http://www.brain-map.org). Images werecaptured using either
Figure 5. Gene targeting strategy for the Tmem26 locus. (A) Targeting construct for Tmem26 conditional inactivation compared to the wild
type allele and the floxed Tmem26 allele after homologous recombination. In the presence of Cre recombinase, the region between LoxP sites will be
excised, including exon 2, exon 2a (red) and the neomycin selection cassette (green). The neomycin selection cassette can be independently excised
by Flp recombinase (frt sites). A Southern probe (open box) and PCR primers (small arrows) external to the targeting construct were used to screen
stem cells for successful homologous recombination. An EcoRV site (E*) was introduced with the targeting construct and was diagnostic during
Southern and PCR assays for 59 LoxP integration. (B) Two transcripts were detected, one lacking exons 2 and 2a as predicted, and another variant in
which exon 3 was also absent. In both cases exon 1 is retained, and the exons after the deleted exons are out of frame. A premature stop codon is
introduced in both cases (C) Southern blot showing the wild type and mutant band arising from Cre-mediated excision (Tmem26
Ex22).
doi:10.1371/journal.pone.0025228.g005
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Ex22/Ex22 mice appear phenotypically normal. (A) Dorsal and (B) ventral views of adult WT and Tmem26
Ex22/Ex22 littermate
mice. (C–J) Alcian blue/alizarin red staining of WT and Tmem26
Ex22/Ex22 adult littermate skeletal preparations. (C) and (D) are at the same
magnification. (E,H) Dorsal, (F,I) ventral and (G,J) lateral views of skull. In (F,I) the mandible has been removed to allow visualisation of the palate.
(K,L) Transverse sections through the secondary palate of 15.5 dpc WT and Tmem26
Ex22/Ex22 embryos. (M) Mean distance between the inner canthi
of the eyes, and (N) mean length of the snout were compared between WT and Tmem26
Ex22/Ex22 adult mice (n=18 female mice, 20 male mice per
genotype). (O) diagram showing the measurements taken. L-snout length; w-distance between the eyes. Error bars represent standard error of the
mean (SEM), statistical analysis (Student’s t-test) revealed no significant difference.
doi:10.1371/journal.pone.0025228.g006
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and DP Controller software (Olympus Corporation).
qRT-PCR
qRT-PCR was conducted using SYBR Green reaction mix and a
7900HT (Applied Biosystems) PCR machine with a 384-well format.
Most wild type adult tissues and all Tmem26
Ex22/Ex22 tissues were
analysed using several different pairs of qRT-PCR primers (sequence
available on request). However, as no obvious variation was observed
between the results generated by the different primer pairs, data
presented came from one primer pair designed to span exons 2 to 4
(Tmem26Fwd;GAAATGCACCATGGAAACC, Tmem26Rev; CGG-
TTCACATACCATGGATAA). qRT-PCR was performed in tripli-
cate on each sample. Primers that amplify Hprt1 were used as an
internal standard (Hprt1Fwd; GCAGTACAGCCCCAAAATGG,
Hprt1Rev; AACAAAGTCTGGCCTGTATCCAA). The mean CT
(cycle number at threshold) of the Hprt1 triplicate of each sample was
deducted from the mean CT of the gene of interest triplicate to
calculate the DCT. Figure 4 shows the mean DCT and standard error
of the mean (SEM) of biological triplicates for each sample type.
Targeting construct production and generation of
Tmem26
c/c and Tmem26
Ex22/Ex22 mice
The Tmem26 conditional inactivation targeting vector, pN9KO,
was based on the backbone vector pOZmod, a derivative of pOzIII.
Three genomic regions from the Tmem26 locus were PCR amplified
and ligated into pOZmod, becoming the 59 homology arm, 39
homology arm (each being approximately 5 kb) and the 1582 bp
targeted region that contains exon2 and exon2a (Targeted region
Fwd:GTTTAATTAACCGAGGGTGACTGTGACT, Targeted
region Rev: TATGTCGACAAATGATGCCAGAACAAGG, 59
Arm Fwd; TGGCGCGCCATTGAGGCAGAGGACATC, 59Arm
Rev; ATGGTACCATGATTTCTGCCACAGGGA, 39 Arm Fwd;
GCAGCGGCCGCACTAGATTAAACAACACTTT, 39 Arm
Rev; TGCCCGCGGAAGTGCAAGTCAGTATGTGT). The tar-
geted region was inserted into pOZmod between the 59 LoxP site and
the neomycin selection cassette (Neo). The 39 LoxP site was positioned at
the other side of the Neo cassette, and therefore introduction of Cre
recombinase would mediate the excision of the exon2-2a region and
theNeocassette. The 3 Tmem26genomicregionswerePCRamplified,
using the Expand Long Template PCR System (Roche), from DNA
extracted from liver tissue of a C57BL/6 mouse.
pN9KO DNA was prepared from E.coli by CsCl density
gradient as described in [27], and linearised using ClaI prior to
electroporation. The ES cell line used for pN9KO electroporation
(C2) is derived from the C57BL/6 strain and was produced and
kindly supplied by Dr Andras Nagy (Samuel Lunenfield Research
Institute, Toronto, Canada). Electroporation of ES cells, and
selection of cell lines with stably incorporated pN9KO, was
performed by standard methods. Neomycin-resistant ES cell lines
were subsequently assayed using both PCR (not shown) and
Southern blot analyses to identify lines in which pN9KO had
undergone correct homologous recombination into the Tmem26
locus. Southern blots were performed as described [27], using
EcoRV. The probe used to identify Tmem26 bands lies outside the
genomic regions that contribute to the pN9KO vector. Correctly
targeted clones were identified by the presence of two bands, a
WT band at 13.6 kb and a targeted band at 10.5 kb.
All injections of ES cells into blastocysts, and implantations of
embryos, were performed essentially as described in [25]. Chimeric
male offspring were bred to C57BL/6 females, and F
1 animals were
screened using a PCR genotyping protocol. The resultant Tmem26
conditional inactivation strain (Tmem26
c) was subsequently maintained
on a C57BL/6 background. Alternatively, F
1 Tmem26
+/c male mice
were crossed to CMV-Cre females (on a C57Bl/6 background) to
produce Tmem26
+/Ex22:CMV-Cre offspring. These offspring were then
mated with C57BL/6 animals to remove CMV-Cre. The resultant
Tmem26
+/Ex22 line was maintained on a C57Bl/6 background.
Genotyping for all Tmem26 alleles used three primers in a triplex
reaction (N9GenoS5417; CAGGATTTGCTCTGGCTGC, N9Gen-
oAS5857; ATGTCTGCCCTTTGCCTCC, N9GenoAS9272; TG-
GAATCCCCATCGCCCTGT) at 60uC annealing temperature.
Expected band sizes were Tmem26
+;392 bp, Tmem26
c;440 bp, Tme-
m26
Ex2;368 bp.
Skeletal preparations and histology
Adult skeletons were stained with Alcian blue (staining cartilage)
and Alizarin red (staining ossified tissues). Adult animals were
euthanased with CO2, skin was removed and carcasses were
placed in boiling water for 30 seconds. Soft tissues were removed
manually. Skeletons were fixed in 100% EtOH, 1% glacial acetic
acid for 4 days, transferred to acetone for three days, rinsed in
distilled H2O and stained for 14 to 28 days in staining solution (1
volume 0.3% alcian blue in 70% EtOH, 1 volume 0.1% alizarin
red in 95% EtOH, 1 volume 100% acetic acid, 17 volumes
EtOH). Skeletons were then rinsed in distilled water and de-
stained in 20% glycerol, 1% potassium hydroxide solution until
intensity of stain was appropriate, changing de-staining solution
every 2–3 days. After destaining, specimens were transferred
through a series of 50%, 80% and 100% glycerol.
Haematoxylin, eosin and toluidine blue histological staining was
performed according to standard protocols [28].
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